The disciplines of pharmacology and physiology touch on virtually every field of the biomedical sciences, presenting endless opportunities to discover disease mechanisms and develop new treatments. This translational approach is at the basis of our work, firmly rooted in the concept of promoting a seamless and continuous transition between the basic and the clinical sciences.
Our faculty pursue a variety of scientific interests in the areas of neurological disorders, cancer therapeutics, pain, cardiovascular and renal physiology, substance abuse, HIV neuropathology and comorbidities. We invite you to visit their laboratory pages and learn more about ongoing research projects and available openings. Feel free to inquire if you have any questions!
New Faculty Positions Available
The Department of Pharmacology & Physiology at Drexel University College of Medicine
announces the opening of tenure-track faculty positions.
Read more [PDF]
Our training programs provide students with a wealth of advantages in considering career opportunities within academic and biopharmaceutical settings. We offer both traditional, research-intensive graduate programs in Pharmacology and Physiology (MS and PhD), as well as a recently developed program in Drug Discovery and Development.
Meet Our Faculty: Priscila Sato, PhD
"We are interested in cardiac hypertrophy and how that develops into decompensated heart failure. We also have another line of research where we're looking at how diabetes leads to cardiac dysfunction. I have a couple of genetic mouse models. We want to really hone down in understanding potential mechanisms of how changes in the pancreas, particularly in the beta islets, impact the heart."
Learn more about Priscila
News and Announcements
Welcome New Faculty
An enthusiastic welcome to the department’s newest members, Drs. Zachary Klase and Rachel Van Duyne. Dr. Van Duyne has been collaborating with Dr. Klase for the last couple of years, and together they join us from University of the Sciences. The Klase Lab focuses on understanding the molecular mechanisms of HIV integration and latency with a main interest in epigenetic regulation and neuropathogenesis in the context of substance abuse.
NIDA Grant for Dr. Gaskill
Congratulations to Peter Gaskill, PhD, on securing an R21 award from the National Institute on Drug Abuse for his project "DAT-Psychostimulant Mediated Dopamine Release Increases Macrophage IL-1beta Production Through NF-kB Activation and Inflammasome Priming."
See all news
See full seminar calendar
Back to Top